Publication

Ragab O, Banerjee R, Park S-J, Patel S, Zhang M, Wang J, Velez M, Demanes DJ, Kamrava M. 2018. Comparison of patient-reported acute urinary and sexual toxicity scores in a 6- versus 2-fraction course of high-dose-rate prostate brachytherapy monotherapy. J Med Imaging Radiat Oncol. 62:109–115. doi:10.1111/1754-9485.12648.

Janczak CM, Calderon IAC, Mokhtari Z, Aspinwall CA. 2018. Polystyrene-Core, Silica-Shell Scintillant Nanoparticles for Low-Energy Radionuclide Quantification in Aqueous Media. ACS Appl Mater Interfaces. 10:4953–4960. doi:10.1021/acsami.7b15943.

Gibson B, Bracamonte E, Krupinski EA, Briehl MM, Barker GP, Weinstein JB, Weinstein RS. 2018. A "Pathology Explanation Clinic (PEC)" for Patient-Centered Laboratory Medicine Test Results. Acad Pathol. 5:2374289518756306. doi:10.1177/2374289518756306.

Sandweiss AJ, Morrison CM, Spichler A, Rozich J. 2018. A case report of clonidine induced syncope: a review of central actions of an old cardiovascular drug. BMC Pharmacol Toxicol. 19:6. doi:10.1186/s40360-018-0198-1.

Segrin C, Badger TA, Sikorskii A, Crane TE, Pace TWW. 2018. A dyadic analysis of stress processes in Latinas with breast cancer and their family caregivers. Psychooncology. 27:838–846. doi:10.1002/pon.4580.

Singh J, Row D, Schaub T, Zeitouni NC. 2018. A Novel, Multidisciplinary Approach in the Treatment of Perianal Paget Disease. Dermatol Surg. 44:1653–1655. doi:10.1097/DSS.0000000000001500.

Carducci M, Shaheen M, Markman B, Hurvitz S, Mahadevan D, Kotasek D, Goodman OB, Rasmussen E, Chow V, Juan G, et al. 2018. A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors. Invest New Drugs. 36:1060–1071. doi:10.1007/s10637-018-0625-6.

Johnson SB, Butow PN, Bell ML, Detering K, Clayton JM, Silvester W, Kiely BE, Clarke S, Vaccaro L, Stockler MR, et al. 2018. A randomised controlled trial of an advance care planning intervention for patients with incurable cancer. Br J Cancer. 119:1182–1190. doi:10.1038/s41416-018-0303-7.

Cusanovich DA, Hill AJ, Aghamirzaie D, Daza RM, Pliner HA, Berletch JB, Filippova GN, Huang X, Christiansen L, DeWitt WS, et al. 2018. A Single-Cell Atlas of In Vivo Mammalian Chromatin Accessibility. Cell. 174:1309–1324.e18. doi:10.1016/j.cell.2018.06.052.

Loescher LJ, Rains SA, Kramer SS, Akers C, Moussa R. 2018. A Systematic Review of Interventions to Enhance Healthy Lifestyle Behaviors in Adolescents Delivered via Mobile Phone Text Messaging. Am J Health Promot. 32:865–879. doi:10.1177/0890117116675785.

Williams KS, Secomb TW, El-Kareh AW. 2018. Additive Damage Models for Cellular Pharmacodynamics of Radiation-Chemotherapy Combinations. Bull Math Biol. 80:1236–1258. doi:10.1007/s11538-017-0316-z.

Lamendella R, Wright JR, Hackman J, McLimans C, Toole DR, Bernard Rubio W, Drucker R, Wong HT, Sabey K, Hegarty JP, et al. 2018. Antibiotic Treatments for Infection Are Associated with Distinct Bacterial and Fungal Community Structures. mSphere. 3. doi:10.1128/mSphere.00572-17.

Sandoval PJ, Zorn KM, Clark AM, Ekins S, Wright SH. 2018. Assessment of Substrate-Dependent Ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates. Mol Pharmacol. 94:1057–1068. doi:10.1124/mol.117.111443.

Lichauco K, Lee MS, Kuhns MS. 2018. Bonds Voyage! A Dissociative Model of TCR-CD3 Triggering Is Proposed. Immunity. 49:786–788. doi:10.1016/j.immuni.2018.11.008.

Sharma AK, Krzeminski J, Weissig V, Hegarty JP, Stewart DB. 2018. Cationic amphiphilic bolaamphiphile-based delivery of antisense oligonucleotides provides a potentially microbiome sparing treatment for C. difficile. J Antibiot (Tokyo). 71:713–721. doi:10.1038/s41429-018-0056-9.

Martinez JA, Yang J, Wertheim BC, Roe DJ, Schriewer A, Lance P, Alberts DS, Hammock BD, Thompson PA. 2018. Celecoxib use and circulating oxylipins in a colon polyp prevention trial. PLoS One. 13:e0196398. doi:10.1371/journal.pone.0196398.

Ross MD, Biswas Roy S, Patil PD, Huang JL, Thawani N, Drosten R, Panchabhai TS. 2018. Coexistent Non-Small Cell Carcinoma and Small Cell Carcinoma in a Patient Presenting with Hyponatremia. Case Rep Pulmonol. 2018:1718326. doi:10.1155/2018/1718326.

Padi M, Quackenbush J. 2018. Detecting phenotype-driven transitions in regulatory network structure. NPJ Syst Biol Appl. 4:16. doi:10.1038/s41540-018-0052-5.

Kulaylat AS, Buonomo EL, Scully KW, Hollenbeak CS, Cook H, Petri WA, Stewart DB. 2018. Development and Validation of a Prediction Model for Mortality and Adverse Outcomes Among Patients With Peripheral Eosinopenia on Admission for Clostridium difficile Infection. JAMA Surg. 153:1127–1133. doi:10.1001/jamasurg.2018.3174.

Remeniuk B, King T, Sukhtankar D, Nippert A, Li N, Li F, Cheng K, Rice KC, Porreca F. 2018. Disease modifying actions of interleukin-6 blockade in a rat model of bone cancer pain. Pain. 159:684–698. doi:10.1097/j.pain.0000000000001139.

Akam EA, Utterback RD, Marcero JR, Dailey HA, Tomat E. 2018. Disulfide-masked iron prochelators: Effects on cell death, proliferation, and hemoglobin production. J Inorg Biochem. 180:186–193. doi:10.1016/j.jinorgbio.2017.12.016.

Rice PFS, Ehrichs KG, Jones MS, Chen H, Hsu C-H, Abril ER, Nagle RB, Besselsen DG, Barton JK, Ignatenko NA. 2018. Does Mutated Oncogene Attenuate the Effect of Sulindac in Colon Cancer Chemoprevention? Cancer Prev Res (Phila). 11:16–26. doi:10.1158/1940-6207.CAPR-17-0230.

Centuori SM, Gomes CJ, Kim SS, Putnam CW, Larsen BT, Garland LL, Mount DW, Martinez JD. 2018. Double-negative (CD27IgD) B cells are expanded in NSCLC and inversely correlate with affinity-matured B cell populations. J Transl Med. 16:30. doi:10.1186/s12967-018-1404-z.

Kumar GS, Clarkson MW, Kunze MBA, Granata D, Wand AJ, Lindorff-Larsen K, Page R, Peti W. 2018. Dynamic activation and regulation of the mitogen-activated protein kinase p38. Proc Natl Acad Sci U S A. 115:4655–4660. doi:10.1073/pnas.1721441115.

Thorne CA, Chen IW, Sanman LE, Cobb MH, Wu LF, Altschuler SJ. 2018. Enteroid Monolayers Reveal an Autonomous WNT and BMP Circuit Controlling Intestinal Epithelial Growth and Organization. Dev Cell. 44:624–633.e4. doi:10.1016/j.devcel.2018.01.024.